ArticleFrontiers in neurology2025
Clinical application of unilateral biportal endoscopic lumbar interbody fusion in lumbar degenerative diseases: a multi-center study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study endeavors to evaluate the clinical efficacy of unilateral biportal endoscopic lumbar interbody fusion (ULIF) in managing lumbar degenerative diseases (LDD) through a multi-center investigation. Methods: One hundred patients diagnosed with LDD between August 2022 and August 2024 were enrolled and allocated to either the ULIF cohort (ULIF group, Results: The ULIF group demonstrated a higher three-month interbody fusion rate than the PLIF group ( Conclusion: ULIF enhances postoperative pain relief, functional recovery, and inflammatory resolution, while simultaneously shortening operative and hospitalization durations, minimizing intraoperative blood loss, and maintaining a favorable safety profile in LDD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.